Noha Maklad

436 total citations
8 papers, 108 citations indexed

About

Noha Maklad is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Noha Maklad has authored 8 papers receiving a total of 108 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Organic Chemistry and 2 papers in Molecular Biology. Recurrent topics in Noha Maklad's work include Bioactive Compounds and Antitumor Agents (1 paper), Chemical Synthesis and Analysis (1 paper) and Liver Disease and Transplantation (1 paper). Noha Maklad is often cited by papers focused on Bioactive Compounds and Antitumor Agents (1 paper), Chemical Synthesis and Analysis (1 paper) and Liver Disease and Transplantation (1 paper). Noha Maklad collaborates with scholars based in United States, Sweden and Australia. Noha Maklad's co-authors include Sauzanne Khalilieh, Heather R. Jordan, Marian Iwamoto, Ka Lai Yee, Rosa I. Sánchez, Fan Li, Hiddo J.L. Heerspink, Zlatko Janeba, Alan H. Ganong and Morris J. Robins and has published in prestigious journals such as Blood, Journal of the American Society of Nephrology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Noha Maklad

8 papers receiving 106 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noha Maklad United States	5	32	27	26	18	14	8	108
Samardeep Gupta United States	7	20 0.6×	27 1.0×	4 0.2×	5 0.3×	2 0.1×	9	220
José Antonio Bernal Spain	6	99 3.1×	7 0.3×	12 0.5×		52 3.7×	11	187
Lalitha Podila United States	4	53 1.7×	30 1.1×	8 0.3×	2 0.1×		4	206
Wenna Chi China	5	53 1.7×	11 0.4×	2 0.1×	7 0.4×	6 0.4×	5	116
Yunong Zeng China	4	47 1.5×	4 0.1×	8 0.3×	2 0.1×	1 0.1×	11	108
Ákos Pál United Kingdom	6	75 2.3×	28 1.0×	2 0.1×	3 0.2×	2 0.1×	9	214
Pierpaolo Dall’Aglio Italy	8	11 0.3×	5 0.2×	1 0.0×	20 1.1×	12 0.9×	11	195
Shripad Chitnis United States	6	30 0.9×	25 0.9×	3 0.1×		2 0.1×	13	159
Chandrika B. Kannadka United States	5	26 0.8×	10 0.4×	9 0.3×			5	94
Hilda A. High Australia	2	28 0.9×	22 0.8×		21 1.2×	2 0.1×	3	124

Countries citing papers authored by Noha Maklad

Since Specialization

Citations

This map shows the geographic impact of Noha Maklad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noha Maklad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noha Maklad more than expected).

Fields of papers citing papers by Noha Maklad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noha Maklad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noha Maklad. The network helps show where Noha Maklad may publish in the future.

Co-authorship network of co-authors of Noha Maklad

This figure shows the co-authorship network connecting the top 25 collaborators of Noha Maklad. A scholar is included among the top collaborators of Noha Maklad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noha Maklad. Noha Maklad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Dwyer, Jamie P., Noha Maklad, Ola Vedin, et al.. (2025). Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension. Journal of the American Society of Nephrology. 37(2). 299–311. 4 indexed citations

2.

Heerspink, Hiddo J.L., Austin G. Stack, Robert Terkeltaub, et al.. (2024). Combination Treatment with Verinurad and Allopurinol in CKD. Journal of the American Society of Nephrology. 35(5). 594–606. 15 indexed citations

3.

Heeney, Matthew M., Miguel R. Abboud, Jessie Githanga, et al.. (2022). Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. Blood. 140(13). 1470–1481. 11 indexed citations

4.

Khalilieh, Sauzanne, Ka Lai Yee, Rosa I. Sánchez, et al.. (2016). Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study. Antimicrobial Agents and Chemotherapy. 61(2). 38 indexed citations

5.

Duplantier, Allen J., Ivan Efremov, Angela C. Doran, et al.. (2009). 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization. Bioorganic & Medicinal Chemistry Letters. 19(9). 2524–2529. 21 indexed citations

6.

Zhang, Lei, Bruce N. Rogers, Allen J. Duplantier, et al.. (2008). 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: A novel series of mGluR2 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 18(20). 5493–5496. 13 indexed citations

7.

Janeba, Zlatko, Noha Maklad, & Morris J. Robins. (2006). Synthesis of 6-(alkoxymethyl)- and 6-(alkylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one analogues. Canadian Journal of Chemistry. 84(4). 561–568. 2 indexed citations

8.

Janeba, Zlatko, Noha Maklad, & Morris J. Robins. (2005). An Efficient Alternative Route To 3,6-Disubstituted-Furo[2,3-d]Pyrimidin-2-One Analogues. Nucleosides Nucleotides & Nucleic Acids. 24(10-12). 1729–1743. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact